Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorThe University of Tennessee, Knoxville

About this trial

The overarching goal of our research is to develop personalized and accessible healthy aging lifestyle interventions aimed at promoting physical activity (PA) and improving health among community-dwelling older adults living alone with cognitive decline (LACD). To achieve this goal, the purpose of this project is to determine whether wearable and app-based mHealth intervention component(s) will contribute to increased PA and improved health outcomes in older adults LACD. Our specific aims are to: identify and evaluate mHealth intervention components that practically and significantly contribute to enhanced mechanistic outcomes (e.g., self-efficacy, outcome expectations) and increased PA (primary outcome) in older adults LACD over a 6-month period; determine the optimal combinations of intervention components for future efficacy testing; elucidate the mechanism of behavioral change (MoBC) and potential outcomes of these intervention components, namely, the mediating effects of MoBC variables (e.g., self-efficacy, outcome expectations) on the relationship between intervention components and change in PA. The first two aims are primary and fully-powered. The third aim is exploratory. The aims will support a refined, data-driven intervention design for a subsequent larger trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participant must be at least 65 years of age older

Participant must be living alone in the U.S. for the next 6 months

Participant must have report mild cognitive decline [We will use a short self-report AD8 measure of cognitive concerns. Those scoring positive on the AD8 (≥2) will qualify as mild cognitive decline];

Participant must own an Android/Apple smartphone

Disqualifiers

Foreign residents or visitors

Trial design

Design model

Factorial

Treatments tested in this trial

  • Fitness app for self-efficacy

    Other intervention

    AI-driven personalized exercise prescription via a fitness app. This targets self-efficacy.

  • Social network via app for social support

    Other intervention

    Participants will be provided access to a social network via app. This targets social support.

  • Health education app targeting outcome expectations

    Other intervention

    Participants are provided with an app-based health education. This targets outcome expectations.

Treatment groups

64 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Group A: Access to all applicationsExperimental treatment 3 interventions
Group B: Access to application 1 & 2Experimental treatment 2 interventions
Group C: Access to application 1 & 3Experimental treatment 2 interventions
Group D: Access to application 1 onlyExperimental treatment 1 intervention
Group E: Access to application 2 & 3Experimental treatment 2 interventions
Group F: Access to application 2 onlyExperimental treatment 1 intervention
Group G: Access to application 3 onlyExperimental treatment 1 intervention
Group H: No access to any applicationNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Fitbit MVPA

Fitbit Inspire 3 Tracker will be used to assess participants' MVPA (active time which includes both fairly active time and very active time). Fairly active; duration associated with light intensity activities, i.e., walking, light cycling, housework (\~3-6 METs). Very active; duration associated with high intensity activities, i.e., running, aerobic workouts (\>6 METs).

Time frame
Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
2

Physical Activity

We will use the Physical Activity Scale for the Elderly to assess PA. Higher scores means more physical activity. (Low activity: \<100; Moderate: 100-250; High: \>250)

Time frame
Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
3

Mechanism of behavior change (MoBC) variables

Psychometrically validated questionnaires will be used to assess beliefs: self-efficacy, social support, and outcome expectations. Self-efficacy; low score indicates low confidence in ability to perform behavior, high score indicates strong confidence. Social support; low score indicates poor support from family or friends, high score indicates great support. Outcome expectation; low score indicates the belief that behavior won't help, high score indicates the belief that the behavior will lead to positive outcome.

Time frame
Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

Secondary outcomes

1

Quality of life (QoL)

We will select the brief Older People's Quality of Life questionnaire to assess quality of life (OPQOL-BRIEF). Minimum: 13 (very poor quality of life) Maximum: 65 (excellent quality of life)

Time frame
Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
2

Psychosocial wellbeing

We will assess wellbeing using the World Health Organization Well-Being Index (WHO-5) questionnaire. 0 -12 - Low well-being; possible depression (screen positive) 13 - 19 - Moderate well-being 20 - 25 - High well-being

Time frame
Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
3

Cognition

To assess older adults' cognition (thinking and memory), we will use the 5-minute Montreal Cognitive Assessment (MoCA). 26 - 30: Normal; Indicates health cognitive functioning for most adults. 18 - 25: Mild Cognitive Impairment (MCI); Shows noticeable memory or thinking issues that do not severely disrupts daily life. 10 - 17: Moderate Cognitive Impairment; Suggests a heightened progression towards early-to-mid stage dementia. Less than 10: Severe Cognitive Impairment.

Time frame
Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The University of Tennessee, Knoxville

Lead sponsor

Arizona State University

Collaborator

Oregon Research Institute

Collaborator

National Institute on Aging (NIA)

Collaborator